The qpcr instruments market in Canada is expected to reach a projected revenue of US$ 87.6 million by 2033. A compound annual growth rate of 7.2% is expected of Canada qpcr instruments market from 2026 to 2033.
The Canada qpcr instruments market generated a revenue of USD 50.7 million in 2025 and is expected to reach USD 87.6 million by 2033.
The Canada market is expected to grow at a CAGR of 7.2% from 2026 to 2033.
In terms of segment, quantstudio was the largest revenue generating type in 2025.
QuantStudio is the most lucrative type segment registering the fastest growth during the forecast period.
Qpcr instruments market data book summary
Market revenue in 2025
USD 50.7 million
Market revenue in 2033
USD 87.6 million
Growth rate
7.2% (CAGR from 2026 to 2033)
Largest segment
Quantstudio
Fastest growing segment
QuantStudio
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
QuantStudio, LightCycler, Cobas 4800/5800/6800/8800, GeneXpert, Rotor-Gene Q, BioFire FilmArray System, BMS Mic System, Cobas Z480, CFX
Key market players worldwide
Thermo Fisher Scientific Inc, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Danaher Corp, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, BioMerieux SA, Azure Biosystems, Bio Molecular Systems
Other key industry trends
In terms of revenue, Canada accounted for 4.3% of the global qpcr instruments market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. qpcr instruments market is projected to lead the regional market in terms of revenue in 2033.
Canada is the fastest growing regional market in North America and is projected to reach USD 87.6 million by 2033.
Canada is anticipated to hold significant market share during the forecast period, owing to its increasing research on oncology & cell therapy. However, cell therapies are still unapproved, which can act as a restraint.
Use of molecular diagnostic devices such as qPCR has been on the rise over the past few years, which can be attributed to an increase in the prevalence of diseases such as HAI & HIV; rapid & early diagnosis leading to better treatment alternatives; and rise in health consciousness.
Canada ranks ninth globally and conducts 5% of global clinical trials conducted. This creates an opportunity for PCR equipment to be used to conduct clinical trials and research. Furthermore, high use and cost of biologics increases the revenue generation of the market.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to QPCR Instruments Market Outlook will help companies and investors design strategic landscapes.
Quantstudio was the largest segment with a revenue share of 29.98% in 2025.
Horizon Databook has segmented the Canada qpcr instruments market based on quantstudio, lightcycler, cobas 4800/5800/6800/8800, genexpert, rotor-gene q, biofire filmarray system, bms mic system, cobas z480, cfx covering the revenue growth of each sub-segment from 2021 to 2033.
Canada is anticipated to hold significant market share during the forecast period, owing to its increasing research on oncology & cell therapy. However, cell therapies are still unapproved, which can act as a restraint.
Use of molecular diagnostic devices such as qPCR has been on the rise over the past few years, which can be attributed to an increase in the prevalence of diseases such as HAI & HIV; rapid & early diagnosis leading to better treatment alternatives; and rise in health consciousness.
Canada ranks ninth globally and conducts 5% of global clinical trials conducted. This creates an opportunity for PCR equipment to be used to conduct clinical trials and research. Furthermore, high use and cost of biologics increases the revenue generation of the market.
Canada Qpcr Instruments Market Type Outlook (Revenue, USD Million , 2021-2033)
7500
QuantStudio
One Step/One Step Plus
LightCycler
cobas 4800/5800/6800/8800
GeneXpert
Rotor-Gene Q
BioFire FilmArray System
BMS Mic System
cobas Z480
CFX
Others
Reasons to subscribe to QPCR Instruments Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of QPCR Instruments Market Outlook databook
Our clientele includes a mix of QPCR Instruments Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada QPCR Instruments Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada QPCR Instruments Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.